Auwaerter Paul Gisbert bought CAPR
January 5, 2026 · Form 4 insider transaction
Auwaerter Paul Gisbert bought 5,420 shares of Capricor Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,420
Price
$0.00
Total value
N/A
InsiderAuwaerter Paul Gisbert
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 5, 2026
Filing dateJanuary 7, 2026
Shares owned after5,420
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares of the award are fully vested and exercisable as of January 5, 2026, the date of the grant. The award pertains to annual board service.